NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
In conjunction with, or as an alternative to, 5-hydroxyindoleacetic acid (5-HIAA) or serum chromogranin A measurements as a first-line test in the diagnosis of carcinoid syndrome. This includes the differential diagnosis of isolated symptoms suggestive of carcinoid syndrome, in particular flushing.
As a second-line test (5-HIAA or serum chromogranin A measurement are first-line tests) in the follow-up of patients with known or treated carcinoid tumors.
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name